CompletedNCT02169271
Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules
Medication studyAges 50+Italy + United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: from 50 years.
- Listed locations
- Houston and 1 more locationSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: November 21, 2014
- Recruitment status
- Completed
- Enrollment listed in the registry
- 109
- Sponsor
- National Cancer Institute (NCI)
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Medication / drug, OTHER
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States, Italy
- Age range
- Over 50 Years
- Official registry ID
- NCT02169271
- Official title
Show the full official title
A Randomized Phase II Trial of Low Dose Aspirin Versus Placebo in High-Risk Individuals With CT-Detected Subsolid Lung Nodules
Get this study by email
Recruitment & locations
CompletedHouston, United States · Milan, Italy
Questions about this study
Who is behind this study?
The study sponsor is National Cancer Institute (NCI), a research institute.
Did this study involve medication?
Yes. The study involved medication, including Aspirin.
Who was this study for?
Listed age limits: from 50 years.
